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Forskolin-pretreatment of A431 cells reduced both intrinsic and epidermal growth factor (EGF)-induced EGF receptor phosphorylation, however, 
phosphorylation of pospholipase C-y (PLC-y) was stimulated under the same conditions. No significant difference was detected in the amount of 
phosphotyrosine of PLC-y between two cultures with or without forskolin treatment followed by EGF. On the other hand, phosphorylation of 
a 47 kDa protein (P47) which cross-reacted with an anti-PLC-y monoclonal antibody, was stimulated by both forskolin and EGF. Phosphorylation 
was exclusively on serine residues in this case. These results indicate that both PLC-y and P47 are posphorylated by a CAMP-dependent protein 
kinase and the EGF-stimulated serine kinase, and suggest hat serine phosphorylation of PLC-y has no effect on ligand-dependent coupling with 
the EGF receptor. 
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1. INTRODUCTION 
EGF receptor tyrosine kinase is essential for EGF- 
induced biochemical reactions such as phosphatidyl- 
inositol turnover which plays an important role in the 
receptor-mediated signal transduction pathway for 
DNA synthesis. Several enzymes regulate the chain of 
reactions and PLC is the key enzyme involved in the 
production of two important second messengers, 
diacylglycerol and inositoltriphosphate. Recently PLC- 
y has been shown to be coupled with receptors of EGF 
and platelet-derived growth factor in a ligand- 
dependent fashion and to be phosphorylated on 
tyrosine residues [l-5]. Furthermore PLC-y was found 
to be a substrate for CAMP-dependent protein kinase 
(protein kinase A) [6]. 
the physiological concentration of EGF in human 
epidermoid carcinoma A43 1 cells [7]. These results in- 
dicate CAMP-mediated biochemical reactions, perhaps 
through protein kinase A, regulate the EGF receptor 
signal transduction pathway. The system of CAMP- 
mediated depression of EGF receptor signal transduc- 
tion in A43 1 cells therefore provides a good opportuni- 
ty to examine the role of serine phosphorylation of 
PLC-7 on its ability to couple with EGF receptors. 
In this report, we demonstrate that CAMP-mediated 
serine phosphorylation of PLC-7 has no effect on the 
degree of tyrosine phosphorylation induced by EGF, 
strongly suggesting that serine phosphorylation of 
PLC-y does not regulate the interaction of PLC-y with 
the EGF receptor. 
On the other hand, we recently demonstrated that 
CAMP modulated not only EGF receptor phosphoryla- 
tion but also EGF-mediated cell growth inhibition at 
2. MATERIALS AND METHODS 
2. I . Cell culturing 
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A431 cells were grown in Dulbecco’s modified Eagle’s medium 
(DMEM) supplemented with 10% fetal bovine serum (FBS). Prior to 
each experiment, the cells were seeded in chemically defined medium 
DMEM plus Ham’s F12 (DMEM/FlZ) supplemented with insulin, 
transferrin, ethanolamine and fibronectin as described previously [8], 
except that 15 mM Hepes buffer (pH 7.4) and 30 nM NarSeGr were 
added. 
Abbreviations: EGF, epidermal growth factor; PLC-y, 
phospholipase C-y type; CAMP, cyclic AMP; protein kinase A, 
2.2. Labeling of cells with P’Pforthophosphate and isolation of the 
radio-labeled EGF receptor, PLC-y and P47 proteins 
CAMP-dependent protein kinase; P47.47 kDa phosphoprotein; SDS- The methods for labeling of the cells with [‘*P]orthophosphate in 
PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis; chemically defined medium and for immunoprecipitation of EGF 
DMEM, Dulbecco’s modified Eagle’s medium; F12, Ham’s F12 receptor, PLC-r and P47 were essentially the same as described 
medium previously [9]. 
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2.3. Phosphoamino acid analysis and tryptic phosphopeptide 3. RESULTS 
Phosphoamino acid analysis was carried out as described previous- 
ly [9] with minor modifications [lo]. The proteins recovered from 
polyacrylamide gels were filtered through an Ultra Free tube 
(Miliipore). Samples were transferred to screw-capped polypropylene 
tubes (Sarstedt) to minimize loss. The samples were hydrolyzed in 
6 N HCl for 2 h at 105°C and HCI was removed by centrifugation 
under reduced pressure (Speed Vat, Savant). The hydrolysates were 
separated by two-dimensional electrophoresis using a Flat Bed Ap- 
paratus Model FBE 3000 (Pharmacia). With the same apparatus, 
tryptic phosphopeptide mapping was carried out essentially as 
described previously [9]. 
We have shown previously that when A431 cells were 
pretreated with reagents which increase CAMP levels, 
the degree of EGF receptor phosphorylation was 
decreased in both intrinsic and EGF-induced 
phosphorylation at a physiological concentration of 
EGF. On the other hand, protein kinase A 
phosphorylates PLC-y but not the other forms of PLC 
161. 
2.4. Materials 
Mouse EGF was obtained from Collaborative Research Inc., for- 
skolin from Sigma, [32P]orthophosphate (carrier free) from ICN. All 
other materials were the same as described previously 191. 
Monoclonal antibodies against PLC-7 were prepared and mixtures of 
these antibodies were used for immunopr~jpitation and im- 
munoblotting as reported by Meisenhelder et al. [3]. Monoclonal an- 
tibody against EGF receptor (clone 528) was obtained from 
Oncogene Science Inc. Molecular weight markers for sodium dodecyl 
sulfate-polyacrylamide g l electrophoresis (SDS-PAGE) were obtain- 
ed from Bio-Rad. 
To confirm the characteristics of the phosphoryla- 
tion of EGF receptor and PLC-y in response to increas- 
ed intracellular CAMP, A431 cells labeled with 32Pi 
were pretreated with 10 FM forskolin for 60 min and 
then incubated with various concentrations of EGF for 
various times (2-10 min). Each cell lysate was 
separated into two groups and subjected to immuno- 
precipitation with antibodies against EGF receptor or 
PLC-r, respectively. As shown in Fig. lA, two major 
and two minor phosphoproteins were specifically im- 
munopre~ipitate~ with &ti-PLC-T mono~lon~ an- 
Fig. 1. Stimulation of phosphorylation of PLCr and P47 by forskolin and EGF. A431 cells (6 x 10’ cells) were seeded in a 60-mm dish containing 
5 ml of DMEM/Fl2 + 4F and cultured for 2 days. After replacement of the medium with phosphate-free F12 + 4F, the cells were cultured in 
the presence of “F, (0.5 mCi/ml) for 6 h. The cells were treated with IOpM forskolin for the last 1 h and incubated for 5 min with various 
concentrations of EGF as indicated at the top of the panel. After lysing the cells, each cell extract was incubated with the complex of 
Staphylococcus uureus (SA)-preimmune IgG for 1 min at 0°C and centrifuged at loo00 x g for 10 min. The cleared lysates were separated into 
two groups, each extract was subjected to immunoprecipitation with SA-preimmune IgG (A) or SA-anti-PLC-y (B). (Right panel) Each equal 
amount of cleared lysate, obtained by the incubation with SA-preimmune IgG twice, was immunopr~ipitat~ with anti-PLC-y antibody or anti- 
EGF receptor antibody. Proteins in the immunoprecipitated materia1 were separated by electrophoresis through 10% SDS-PAGE. 
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tibodies as reported previously [3]; 155 kDa (PLCy), 
100,84 and 47 kDa (P47). At least two proteins (PLC-y 
and P47) were also detected in immunoblotting with 
anti-PLC-y (data not shown) indicating that these two 
phosphoproteins have similar antigenicity, but are like- 
ly distinct proteins. As expected, while forskolin 
pretreatment decreased both intrinsic and EGF-induced 
(4 nM EGF) phosphorylation of the EGF receptor, it 
stimulated the phosphorylation of both PLC-y and P47 
(Fig. 1B). The approximately 1.5-fold stimulation was 
reproducible. While a CAMP-mediated depression of 
EGF receptor phosphorylation disappeared in response 
to high concentration of EGF (50 nM), no such a dose 
effect was detected in phosphorylation of PLC-7 and 
P47. 
We have carried out phosphoamino acid analysis of 
both PLC-7 and P47. As shown in Fig. 2A and B, 
while EGF-dependent tyrosine phosphorylation was 
observed in PLC-y, P47 contained entirely phospho- 
serine in the presence or absence of EGF. The amounts 
of phosphotyrosine and phosphoserine in PLC-7 were 
estimated both in the cells pretreated with and without 
forskolin followed by EGF. Although the degree of 
serine phosphorylation of PLC-y increased in the 
forskolin-treated culture compared to that in the un- 
treated culture, the content of phosphotyrosine was 
almost the same in both cultures (Table I). The relative 
amount of phosphorylation on serine and tyrosine 
residues of PLC-y in both cultures was not affected 
Fig. 2. Phosphoamino acid analysis of PLC-y and P47 from A431 
cells treated with forskolin followed by EGF. “P-labeled A431 cells 
Fig. 3. Tryptic phosphopeptide maps of PLC-y and P47 from A431 
cells treated with or without forskolin followed by EGF. 
were treated with or without 10 PM forskolin for 60 min followed by Radiolabeled PLC-y and P47 were isolated as described in the legend 
4 nM EGF for the times indicated. The cell lysates were of Fig. 1 and subjected to tryptic peptide mapping as described in 
immunoprecipi~ted with anti-PLC-y monoclonal antibodies and section 2. Results for PLC-y from EGF-treated cells (a), from 
PLC-7 and P47 were separated by electrophoresis through SDS- forskolin-pretreated and EGF-treated cells (b), for P47 from 
PAGE and subjected to phosphoamino acid analysis as described in untreated (c) and forskolin-treated cells (d) are shown. The 
section 2. Autoradiograms of PLC-7 (A, C) and P47 (B) are arrowhead in (d) indicates the new phosphopeptide induced by 
presented. ‘0’ indicates where the samples were applied. forskolin. ‘0’ indicates where the samples were applied. 
Table I 
Quantitative analysis of phosphotyrosine in PLCr 
Experiment EGF Ratio of degree of Ratio of phospho- 
no. (nM) PLC-y tyrosine 
phosphorylationa contentb 
(forskolin + / -) (forskolin f I -) 
1 0 1.13 + O.OV ND 
2 4 1.50 + 0.27** 1.03 f 0.40** 
3 10 1.16 * 0.04** 1.30 * 0.08** 
a The degree of PLC-y phoshorylation was determined by measuring 
the radioactivity in 155 kDa bands from the SDS-PAGE gel 
b Radioactivity in phosphot~osine on thin-layer plate was measured 
by scraping the spots identified by ninhydrin-stained standard 
marker of each phosphoamino acid and autoradiography. Each 
sample of scraped powder was counted in 1 ml of ACS II 
(Amersham) liquid scintillation solution. The background count 
was subtracted from each value in both cases 
32P-labeled PLC-y obtained from the cells with or without forskolin 
treatment followed by exposure to 0,4 or 10 nM EGF for 5 min were 
subjected to t-dimensional phosphoamino acid analysis. ND, not 
determined. * Range of 2 independent experiments. ** SD of 3 
independent experiments 
during the incubation with EGF (2-10 min) (Fig. 2C). 
Comparable tyrosine phosphorylation of PLC-y in 
both cultures was confirmed using another method; the 
combination of immunoprecipitation with anti-PLC-y 
and immunoblotting with anti-phosphotyrosine an- 
tibody (data not shown). 
Fu~hermore to evaluate the cont~bution of 
phosphorylation on specific sites of PLC--y, the 
phosphopeptide maps of PLC-7 were compared bet- 
ween the two cultures. No distinctive decrease of any 
phosphopeptides was detected in the tryptic 
phosphopeptide maps of PLC-y between them 
(Fig. 3a,b), while forskolin induced one new 
phosphopeptide in P47 (Fig. 3c,d). The peptides pro- 
duced from P47 are quite different from those of PLC- 
159 
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y indicating that P47 is not a degraded form of PLC-y, 
These results indicate that serine phosphorylation of 
PLC-y stimulated by forskolin has no effect on the 
tyrosine phosphorylation of PLC-7 by the EGF recep- 
tor tyrosine kinase. 
Assuming that the degree of tyrosine phosphoryla- 
tion of PLC-7 reflects the strength of the interaction 
between the EGF receptor and PLC-y, our data suggest 
that serine phosphorylation of PLC-7 by protein kinase 
A does not regulate the coupling ability of PLC-y with 
EGF receptors in a ligand-dependent fashion. 
signal transduction in platelets [13,14] where CAMP 
enhancing agents also induce inhibitory effects [ 11,151. 
One of the small G proteins was phosphorylated by 
protein kinase A both in vitro [ 16,171 and in vivo [ 161. 
Although we cannot as yet correlate the relationship 
between P47 in A431 cells described here and the 
47 kDa protein in platelets, nor the involvement of G 
proteins in the EGF receptor system, these kinds of 
molecules might be involved in the regulation of the 
ligand-dependent activation of PLC, not only in 
platelets but also in EGF receptor pathways [lS]. 
4. DISCUSSION 
Since the CAMP-mediated modulation of the EGF 
receptor signal transduction system in A431 cells is 
related to the inhibition of DAG production [7], we 
supposed that serine phosphorylation of PLC-+y by pro- 
tein kinase A might be involved in this regulatory pro- 
cess. We found no effect of serine phosphorylation of 
PLC-y on inhibition of PLC-y tyrosine phosphoryla- 
tion by the EGF receptor. We also focused on 
phosphorylation of P47 to examine its possible con- 
tribution to the system. The results demonstrated that 
treatment of A431 cells with forskolin, EGF or for- 
skolin followed by EGF increased the degree of 
phosphorylation of PLC-y and P47. EGF-dependent 
tyrosine phosphorylation was found in PLC-y but not 
in P47. We compared the degree of tyrosine 
phosphorylation of PLC-y from cells with or without 
forskolin treatment followed by exposure to EGF at a 
physiological concentration for various periods 
(2-10 min). However, no distinctive difference in the 
amount of phosphotyrosine in the proteins was 
detected between the two cultures, while EGF-induced 
EGF receptor phospho~lation was depressed by 
forskolin-pretreatment. 
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